Phase III clinical trials of atezolizumab in combination with chemotherapy in chemotherapy-naive patients with advanced NSCLC

被引：0

作者：

Mok, T. S. K. ^{[1
]}

Cappuzzo, F. ^{[2
]}

Jotte, R. M. ^{[3
]}

Reck, M. ^{[4
]}

Papadimitrakopoulou, V. ^{[5
]}

Sandler, A. ^{[6
]}

Waterkamp, D. ^{[6
]}

Verret, W. ^{[6
]}

Shen, Y. ^{[7
]}

Socinski, M. A. ^{[8
]}

机构：

[1] Chinese Univ Hong Kong, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China

[2] Osped Civile, Ist Toscano Tumori, Livorno, Italy

[3] Rocky Mt Canc Ctr, Med Oncol, Denver, CO USA

[4] Lung Clin Grosshansdorf, Dept Thorac Oncol, Grosshansdorf, Germany

[5] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[6] Genentech Inc, Clin Sci, San Francisco, CA 94080 USA

[7] Genentech Inc, Biostat, San Francisco, CA 94080 USA

[8] Univ Pittsburgh, Med Ctr, Div Hematol Oncol, Pittsburgh, PA USA

来源：

ANNALS OF ONCOLOGY | 2015年 / 26卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

356TiP

引用

页码：106 / 106

页数：1

共 50 条

[31] A phase II trial of gemcitabine and docetaxel in patients with chemotherapy-naive, advanced nonsmall cell lung carcinoma
Popa, IE
Stewart, K
Smith, FP
Rizvi, NA
CANCER, 2002, 95 (08) : 1714 - 1719
[32] A phase II study of erlotinib and sorafenib in chemotherapy-naive patients with locally advanced/metastatic non-small cell lung cancer (NSCLC)
Lind, J. S.
Dingemans, A. C.
Groen, H. J.
Smit, E. F.
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
[33] A phase II study of erlotinib and sorafenib in chemotherapy-naive patients with locally advanced/metastatic non-small cell lung cancer (NSCLC)
Lind, Joline S.
Dingemans, Anne-Marie C.
Groen, Harry J.
Smit, Egbert F.
JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S412 - S413
[34] Association of frailty with chemotherapy toxicity in chemotherapy-naive older patients with cancer
Ilgın Akbıyık
Deniz Yüce
Ayşe Kars
Meltem Gülhan Halil
Supportive Care in Cancer, 2022, 30 : 9975 - 9981
[35] Phase III study of atezolizumab (atezo) vs chemotherapy (chemo) in patients (pts) with treatment-naive advanced, recurrent or metastatic NSCLC unsuitable for platinum (plat)-based chemo
Lee, S. M.
Schulz, C.
Cardona, A.
Bartakova, P.
Peters, S.
ANNALS OF ONCOLOGY, 2017, 28
[36] Atezolizumab better than chemotherapy in treating NSCLC in a Phase 3 clinical trial
不详
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2017, 13 (02) : 251 - 251
[37] Comprehensive genomic profiling for chemotherapy-naive advanced gastrointestinal malignancies
Kondo, Tomohiro
Quy Pham Nguyen
Matsubara, Junichi
Fukuyama, Keita
Nomura, Motoo
Funakoshi, Taro
Funakoshi, Mari
Sakamoto, Hitomi
Ashida, Kanami
Mukai, Kumi
Uemoto, Shinji
Sakai, Yoshiharu
Seno, Hiroshi
Minamiguchi, Sachiko
Haga, Hironori
Kosugi, Shinji
Kanai, Masashi
Matsumoto, Shigemi
Muto, Manabu
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
[38] COMBINATION CHEMOTHERAPY WITH BEVACIZUMAB, DOCETAXEL AND CARBOPLATIN FOR CHEMOTHERAPY-NAIVE PATIENTS WITH NON-SQUAMOUS CELL LUNG CARCINOMA: PHASE II STUDY.
Matsumoto, Masaru
Takiguchi, Yuichi
Minato, Kouichi
Yoshimori, Kozo
Okamoto, Hiroaki
Kuribayashi, Hidehiko
Ando, Masahiro
Shingyoji, Masato
Noro, Rintaro
Gemma, Akihiko
JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1177 - S1178
[39] Evaluation of bexarotene (Targretin®) in combination with cisplatin and vinorelbine in chemotherapy-naive patients with advanced stage IIIb/IV non-small cell lung cancer (NSCLC)
Ramlau, R
Zatloukal, P
Tadokoro, H
Jassem, J
Hao, D
Orlov, S
Gottfried, M
Mabry, M
Negro-Vilar, A
Dziewanowska, Z
LUNG CANCER, 2005, 49 : S266 - S266
[40] A randomized phase III trial comparing bexarotene/cisplatin/vinorelbine versus cisplatin/vinorelbine in chemotherapy-naive patients with advanced or metastatic non-small cell lung cancer (NSCLC).
Jassem, J
Zatloukal, P
Ramlau, R
Schwarzenberger, PO
Orlov, S
Rodrigues-Pereira, J
Temperley, GJ
Mabry, M
Negro-Vilar, A
Dziewanowska, Z
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 1095S - 1095S

← 1 2 3 4 5 →